How much funding can be received?

There is no informations about how much funding can be received.

What is the deadline to apply?

The deadline to apply is not specified.

Who are the financial supporters of the NRC — Human Health Therapeutics Research Centre?

NRC — Human Health Therapeutics Research Centre is funded by National Research Council Canada (NRC), Government of Canada

What are NRC — Human Health Therapeutics Research Centre's eligibility criterias?

The applicant must collaborate with the National Research Council's Human Health Therapeutics Research Centre. The project must involve the development of innovative biologics, such as cell and gene therapies.

NRC — Human Health Therapeutics Research Centre

grant_single|update January 24, 2025

Canada

Collaborate on human health therapeutics R&D

grant_single_labels|menu_summary

grant_single_labels|menu_preview

grant_single_labels|menu_projects

grant_single_labels|menu_admissibility

grant_single_labels|menu_criteria

grant_single_labels|menu_apply

grant_single_labels|menu_otherInfo

grant_single_labels|menu_documents

grant_single_labels_website|summary

grant_single|eligibleFinancing

grant_single|noCondition

grant_single|deadlines

grant_single|openingDate November 14, 2019

grant_single|financingType

Researchers And Facilities

Expert Advice

grant_single|eligibleIndustries

Manufacturing
Professional, scientific and technical services
Health care and social assistance

grant_single|grantors

National Research Council Canada (NRC)
Government of Canada

grant_single|status

grant_card_status|open

grant_single_labels_website|preview

Access technical and advisory services, research facilities and licensing opportunities for human health therapeutics research.

grant_single_labels_website|projects

grant_single|admissibleProjectsExample

$ 750,000

Creation of an innovative biologic to tackle autoimmune diseases

$ 900,000

Research and development of novel biologics for cancer treatment

$ 600,000

Development of a new gene therapy targeting rare genetic disorders

$ 750,000

Production of a novel biologic for infectious disease treatment

$ 850,000

Development of cell therapy for treating cardiovascular diseases

$ 400,000

Optimization of biomanufacturing processes for complex biologics

grant_single_labels_website|admissibility

grant_eligibility_criteria|eligible_expenses

This grant supports initiatives aimed at advancing biologics development and production, with a focus on tackling complex health challenges. Eligible projects include collaboration across research and development, innovative production processes, and therapy advancements.

Design and development of innovative biologics for emerging infections, cancer, and neurological diseases.
Biomanufacturing improvements to optimize production processes for complex biologics.
Advancement of cell and gene therapies through collaborative projects.
Preclinical research and development utilizing in vivo and in vitro testing.
Scaling up bioprocesses for clinical trial material production compliant with GMP.
Collaborative research initiatives to combat antimicrobial resistance.
Development of CAR T-cell cancer therapies made in Canada.

grant_single_labels_website|criteria

There are evaluation and selection criteria for this grant. The evaluation and selection criteria are as follows:

Relevance of the project to advancing novel biologics
Scientific merit and innovation of the proposed research
Feasibility and technical soundness of the project
Alignment with the organization's strategic priorities
Potential impact on public health and patient outcomes

grant_single_labels_website|apply

Preliminary Research and Collaboration

Review the research publications and programs to identify areas of expertise that align with your project.
Contact Sue Twine or Paul Payette to discuss potential collaboration opportunities and gain insights about the grant application process.

Draft Proposal

Prepare a proposal that outlines the project's objectives, research methodologies, and anticipated outcomes.
Include details about how your project will contribute to the advancement of biologics, biomanufacturing, or cell and gene therapies.

Compile Supporting Documents

Gather all necessary documents including project timelines, budgets, letters of support from collaborators, and CVs of key team members.
Ensure all documents adhere to the grant's guidelines and requirements.

Submit Application

Email the completed application and supporting documents to the appropriate contact as specified, such as Susan.Twine@nrc-cnrc.gc.ca or Paul.Payette@nrc-cnrc.gc.ca.
Make sure to submit the application before any specified deadline to ensure consideration.

Confirmation and Follow-Up

Await confirmation of receipt from the grant body.
Follow up if needed, using the contact information provided, to ensure the application is being processed.

grant_single_labels_website|otherInfo

Here are additional relevant details for this grant:

Collaboration with industry, hospitals, health networks, academia, and government is encouraged to advance novel biologics.
Access to multidisciplinary expertise and leading-edge facilities is available for the biologics development process, from discovery to clinical material production.
Support for generating high-potential candidates using advanced proprietary technologies is provided.
Preclinical R&D capabilities include small-scale manufacturing and both in vivo and in vitro testing expertise.
Bioprocess improvements can be conducted in specialized R&D labs focusing on analytics, modelling, and intensification.
Production facilities are available for optimizing bioprocesses and producing clinical trial materials compliant with good manufacturing practices (GMP).
A directory of science professionals and researcher profiles is accessible, offering insights into their projects and expertise.